Enzymatic characteristics of the monkey endometrium during ovulatory and anovulatory cycles and under hormonal contraception treatment.
D000463:Algestone Acetophenide / Q000494:pharmacology; D000818:Animals; D001219:Aspartate Aminotransferases / Q000032:analysis; D050260:Carbohydrate Metabolism; D004796:Clinical Enzyme Tests; D004717:Endometrium / Q000201:enzymology* / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D005956:Glucose-6-Phosphate Isomerase / Q000032:analysis; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D005969:Glutamate Dehydrogenase / Q000032:analysis; D005993:Glycerolphosphate Dehydrogenase / Q000032:analysis; D000882:Haplorhini; D007521:Isocitrate Dehydrogenase / Q000032:analysis; D008251:Macaca; D008291:Malate Dehydrogenase / Q000032:analysis; D010060:Ovulation / Q000187:drug effects*; D010733:Phosphoglucomutase / Q000032:analysis; D011247:Pregnancy; D011278:Pregnanes / Q000494:pharmacology*; D011372:Progestins / Q000494:pharmacology*
D011278:Pregnanes; D011372:Progestins; D004958:Estradiol; D005993:Glycerolphosphate Dehydrogenase; D008291:Malate Dehydrogenase; D007521:Isocitrate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D005969:Glutamate Dehydrogenase; D001219:Aspartate Aminotransferases; D005956:Glucose-6-Phosphate Isomerase; D010733:Phosphoglucomutase; D000463:Algestone Acetophenide